Xingfa Huo

发表

Immune Checkpoint Inhibitors Plus Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis.

Yonghui Zheng, Jinming Li, Zitao Li, 2021 .

Impact of intestinal dysbiosis on breast cancer metastasis and progression

Mingxue Yuan, Qiqi Xie, Guoshuang Shen, 2022, Frontiers in Oncology.

Watson for oncology decision system for treatment consistency study in breast cancer

Guoshuang Shen, Xingfa Huo, Fuxing Zhao, 2022, Clinical and Experimental Medicine.

Case report of double superior vena cava and double odd vein with hypoplastic left brachiocephalic vein

Xingfa Huo, Haowei Lu, Guoyuan Li, 2022, The Journal of international medical research.

Impact of platinum-based chemotherapy on the prognosis of early triple-negative breast cancer: a systematic review and meta-analysis

F. Du, Zitao Li, Qiqi Xie, 2022, Clinical and Experimental Medicine.

Meta-Analysis of HER2-Enriched Subtype Predicting the Pathological Complete Response Within HER2-Positive Breast Cancer in Patients Who Received Neoadjuvant Treatment

F. Du, F. Zheng, Guoshuang Shen, 2021, Frontiers in Oncology.

Cyclin-dependent kinase 4 and 6 inhibitors in combination with neoadjuvant endocrine therapy in estrogen receptor-positive early breast cancer: a systematic review and meta-analysis

Jinming Li, Zitao Li, Guoshuang Shen, 2022, Clinical and Experimental Medicine.

Association of Cyclin-Dependent Kinases 4 and 6 Inhibitors With Survival in Patients With Hormone Receptor–Positive Metastatic Breast Cancer

F. Du, Jinming Li, Xingfa Huo, 2020, JAMA network open.

Comparing Biomarkers for Predicting Pathological Responses to Neoadjuvant Therapy in HER2-Positive Breast Cancer: A Systematic Review and Meta-Analysis

F. Du, Zitao Li, Qiqi Xie, 2021, Frontiers in Oncology.

Identification of the GTPase IMAP family as an immune-related prognostic biomarker in the breast cancer tumor microenvironment.

Jinming Li, Qiqi Xie, Guoshuang Shen, 2021, Gene.

Treatment options for patients with human epidermal growth factor 2-positive breast cancer brain metastases: A systematic review and meta-analysis

Jinming Li, Qiqi Xie, Guoshuang Shen, 2023, Frontiers in Oncology.

The role of capecitabine-based neoadjuvant and adjuvant chemotherapy in early-stage triple-negative breast cancer: a systematic review and meta-analysis

F. Du, Jinming Li, Xingfa Huo, 2021, BMC Cancer.

Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysis

Jinming Li, Zitao Li, Guoshuang Shen, 2021, BMC Cancer.

Efficacy of anti-HER2 drugs in the treatment of patients with HER2-mutated cancers: a systematic review and meta-analysis

Guoshuang Shen, Xingfa Huo, Fuxing Zhao, 2023, Clinical and Experimental Medicine.

Comparative efficacy and safety of first-line neoadjuvant treatments in triple-negative breast cancer: systematic review and network meta-analysis.

Jinming Li, Guoshuang Shen, Xingfa Huo, 2022, Clinical and experimental medicine.

Cyclin-dependent kinase 4 and 6 inhibitors in combination with neoadjuvant endocrine therapy in estrogen receptor-positive early breast cancer: a systematic review and meta-analysis

Jinming Li, Zitao Li, Guoshuang Shen, 2022, Clinical and Experimental Medicine.

Multi-omics analysis of expression profile and prognostic values of connexin family in LUAD

Bowen Dong, N. Zhou, Xiaochun Zhang, 2023, Journal of Cancer Research and Clinical Oncology.

Nomogram for predicting the risk and prognosis of lung metastasis of four subtypes of breast cancer: A population-based study from SEER

Xingfa Huo, Dengfeng Ren, Jiuda Zhao, 2024, Cancer Pathogenesis and Therapy.